Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rapid Micro Biosystems (RPID) Accumulated Expenses (2020 - 2025)

Historic Accumulated Expenses for Rapid Micro Biosystems (RPID) over the last 6 years, with Q3 2025 value amounting to $6.6 million.

  • Rapid Micro Biosystems' Accumulated Expenses fell 610.97% to $6.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.6 million, marking a year-over-year decrease of 610.97%. This contributed to the annual value of $7.2 million for FY2024, which is 2715.25% down from last year.
  • According to the latest figures from Q3 2025, Rapid Micro Biosystems' Accumulated Expenses is $6.6 million, which was down 610.97% from $5.7 million recorded in Q2 2025.
  • Rapid Micro Biosystems' 5-year Accumulated Expenses high stood at $11.6 million for Q3 2021, and its period low was $5.0 million during Q1 2025.
  • Over the past 5 years, Rapid Micro Biosystems' median Accumulated Expenses value was $7.1 million (recorded in 2024), while the average stood at $7.6 million.
  • Per our database at Business Quant, Rapid Micro Biosystems' Accumulated Expenses skyrocketed by 6406.67% in 2021 and then tumbled by 4174.3% in 2022.
  • Quarter analysis of 5 years shows Rapid Micro Biosystems' Accumulated Expenses stood at $10.9 million in 2021, then decreased by 25.35% to $8.2 million in 2022, then grew by 21.56% to $9.9 million in 2023, then decreased by 27.15% to $7.2 million in 2024, then dropped by 8.44% to $6.6 million in 2025.
  • Its Accumulated Expenses was $6.6 million in Q3 2025, compared to $5.7 million in Q2 2025 and $5.0 million in Q1 2025.